Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Pharmaceutical Retailersβ
2026-06-08HKPD3Initial Statement of Beneficial Ownership
This filing reports that Wu Jingyan, a director at Cellyan Biotechnology Co., Ltd (HKPD), has no securities owned as of March 18, 2026. The filing is an initial statement of beneficial ownership....
Nano CapPharmaceutical Retailers
2026-06-08HKPD3Director Mike Yao Zhou Reports No Securities Ownership in Cellyan Biotechnology Co., Ltd
This Form 3 filing reports that Mike Yao Zhou, a director of Cellyan Biotechnology Co., Ltd (ticker: HKPD), filed a statement of beneficial ownership indicating he holds no securities in the company as of March 18, 2026. The filing was signed on June 2, 2026, and confirms Zhou's position as a director but not as an off...
Nano CapPharmaceutical Retailers